Emory University Bei Gene, Ltd. Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $2.15 Million - $2.64 Million	-17,807 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$113.99 - $146.86 $26,445 - $34,071	-232 Reduced 1.29%	17,807 $2.21 Million
Q1 2019 May 09, 2019	SELL	$122.82 - $151.83 $15,843 - $19,586	-129 Reduced 0.71%	18,039 $2.38 Million
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $1.94 Million - $3.18 Million	18,168 New	18,168 $2.55 Million

217

42.1M

106K

93.1K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $21B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.